Post-Market Study of JUVÉDERM VOLIFT™ With Lidocaine for the Correction of Nasolabial Folds

NACompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

June 1, 2012

Primary Completion Date

March 6, 2014

Study Completion Date

March 6, 2014

Conditions
Moderate to Severe Nasolabial Folds
Interventions
DEVICE

Crosslinked hyaluronic acid dermal filler

All treatment details are at the discretion of the Investigator and should be guided by the Directions for Use. Up to 3 treatments will be administered: Initial treatment, optional top-up treatment at Day 14 post-initial treatment, and optional repeat treatment at Month 12 post-initial treatment.

Trial Locations (3)

Unknown

Cologne

Darmstadt

Naarden

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Allergan

INDUSTRY

NCT01680497 - Post-Market Study of JUVÉDERM VOLIFT™ With Lidocaine for the Correction of Nasolabial Folds | Biotech Hunter | Biotech Hunter